Published in Rev Epidemiol Sante Publique on April 01, 1996
Diabetes in sub-saharan Africa: kenya, mali, mozambique, Nigeria, South Africa and zambia. Int J Diabetes Dev Ctries (2008) 1.33
The challenge of preventing cardiovascular disease in Tunisia. Prev Chronic Dis (2005) 0.84
Development and validation of a food photography manual, as a tool for estimation of food portion size in epidemiological dietary surveys in Tunisia. Libyan J Med (2016) 0.75
The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. Hum Exp Toxicol (2012) 1.39
Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium. Biomed Pharmacother (1994) 1.23
Waist circumference cut-off points for identification of abdominal obesity among the tunisian adult population. Diabetes Obes Metab (2007) 1.16
Visualization of inhibitory Ly49 receptor specificity with soluble major histocompatibility complex class I tetramers. Eur J Immunol (2000) 1.09
MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. J Immunol (2001) 1.01
Prevalence of metabolic abnormalities in the Tunisian adults: a population based study. Diabetes Metab (2006) 1.00
Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa. Protein Sci (1994) 0.98
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. J Med Virol (2005) 0.97
Peptide dependency and selectivity of the NK cell inhibitory receptor Ly-49C. Eur J Immunol (1999) 0.97
T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol (2000) 0.96
[Hydatid cyst of the pancreas]. J Chir (Paris) (2005) 0.95
[Hypothyroid dilated cardiomyopathy]. Ann Cardiol Angeiol (Paris) (2004) 0.95
[Etiologic factors in primary bronchial carcinoma in Tunisia]. Tunis Med (1993) 0.93
Investigations into the cross-reactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins. J Pept Res (1998) 0.91
The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65. Eur J Immunol (2001) 0.91
Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells. Immunol Lett (1998) 0.90
[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)]. C R Acad Sci III (1986) 0.89
[Ramadan fasting in type 2 diabetes mellitus]. Ann Endocrinol (Paris) (2006) 0.89
Specific lysis of murine cells expressing HLA molecules by allospecific human and murine H-2-restricted anti-HLA T killer lymphocytes. Eur J Immunol (1986) 0.89
Ochratoxin A in human blood in relation to nephropathy in Tunisia. Hum Exp Toxicol (1995) 0.89
[Scorpion sting and acute interstitial nephropathy: Apropos of 1 case]. Med Trop (Mars) (2000) 0.87
One-year follow-up of vaccine therapy in HIV-infected immune-deficient individuals: a new strategy. J Acquir Immune Defic Syndr (1992) 0.87
[Necrosis of the glans penis]. Rev Med Interne (2010) 0.87
Hydatid cyst of the rib: a new case and review of the literature. Case Rep Med (2010) 0.86
A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Int Immunol (1998) 0.86
Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Proc Natl Acad Sci U S A (1993) 0.86
[A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension]. J Pharm Belg (1996) 0.86
Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol (1995) 0.85
Aerobic training programs and glycemic control in diabetic children in relation to exercise frequency. J Sports Med Phys Fitness (2011) 0.84
[Desmoid cervical tumour following the placing of an internal jugular catheter]. Presse Med (2004) 0.84
[Cardiac sarcoidosis revealed by ventricular tachycardia]. Tunis Med (2001) 0.83
Anti-cardiolipin and anti-beta 2-glycoprotein I antibodies in celiac disease. Pathol Biol (Paris) (2011) 0.83
[Benign granular cell anal tumor]. Presse Med (2003) 0.82
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. Br J Haematol (2001) 0.82
Impaired MHC class I (H-2Dd)-mediated protection against Ly-49A+ NK cells after amino acid substitutions in the antigen binding cleft. Eur J Immunol (1998) 0.82
Hemolytic uremic syndrome and prostatic adenocarcinoma. Clin Nephrol (1987) 0.82
[The first Tunisian cardiovascular diseases register: processes and results]. Rev Epidemiol Sante Publique (2004) 0.82
Fine characterization of a V3-region neutralizing epitope in human immunodeficiency virus type 2. Virus Res (1999) 0.82
Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed Pharmacother (1994) 0.82
[Primary non-Hodgkin's malignant lymphoma of the adrenal gland. Case report and review of the literature]. Prog Urol (1999) 0.81
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization. Virology (2000) 0.81
[Incidence of surgical wound infections a prospective study in the Rabat Mohamed-V military hospital, Morocco]. Med Mal Infect (2005) 0.81
Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? Cell Death Differ (1995) 0.81
"Kinoids": the basis for anticytokine immunization and their use in HIV infection. Cell Mol Biol (Noisy-le-grand) (1995) 0.80
Enhanced dendritic cell-driven proliferation and anti-HIV activity of CD8(+) T cells by a new phenothiazine derivative, aminoperazine. J Immunol (2001) 0.80
[High prevalence and incidence of hepatitis C virus infections among dialysis patients in the East-Centre of Tunisia]. Pathol Biol (Paris) (2004) 0.80
A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gp160-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. J Acquir Immune Defic Syndr (1992) 0.80
Automat: a novel software system for the systematic search for protein (or DNA) similarities with a notable application to autoimmune diseases and AIDS. Comput Appl Biosci (1994) 0.80
[Primary hypothyroidism and glomerular involvement]. Ann Endocrinol (Paris) (1991) 0.79
Automat and BLAST: comparison of two protein sequence similarity search programs. Comput Appl Biosci (1995) 0.79
Effect of tea decoction given to rats ad libitum for a relatively long time on body weight gains and iron, copper, zinc, magnesium concentrations in blood, liver, duodenum and spleen. Ann Nutr Metab (1997) 0.78
[Coarctation of the abdominal aorta: apropos of 4 cases with a review of the literature]. Tunis Med (1988) 0.78
[Prevalence of endemic goiter in the north western region of Tunisia--1993]. Tunis Med (1994) 0.78
[Food intake and energy expenditure in high school athletes before, during and after the month of Ramadan: effect of fasting on performance]. Tunis Med (1993) 0.78
Cloning, expression, purification, crystallization and preliminary X-ray analysis of the pilus-associated sortase C from Streptococcus pneumoniae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.78
[Blood groups and open-angle glaucoma in Tunisia]. J Fr Ophtalmol (2007) 0.78
Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum Exp Toxicol (1999) 0.78
Characterization of neutralizing sites in the second variable and fourth variable region in gp125 and a conserved region in gp36 of human immunodeficiency virus type 2. Viral Immunol (1999) 0.77
Cyclosporine A treatment for human immunodeficiency virus-infected transplant recipients. Transplant Proc (1987) 0.77
[Serum copper levels in obesity: a study of 32 cases]. Tunis Med (2001) 0.77
Enhancement of cyclosporine A nephrotoxicity by diclofenac. Clin Nephrol (1987) 0.77
Removal of gp160 induced bio-hazards for a safe AIDS vaccine candidate. Biomed Pharmacother (1992) 0.77
The role of an exposed loop in the alpha2 domain in the mouse MHC class I H-2Dd molecule for recognition by the monoclonal antibody 34-5-8S and the NK-cell receptor Ly49A. Scand J Immunol (2002) 0.77
The predictors of early mortality in patients starting chronic hemodialysis. Saudi J Kidney Dis Transpl (2007) 0.77
HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed Pharmacother (1993) 0.77
[Dietary intake in the urban and rural populations of the Cap-Bon]. Rev Epidemiol Sante Publique (1998) 0.77
[Comparative effects of the WHO solution and of a simplified solution in infants with acute diarrhea]. Ann Pediatr (Paris) (1985) 0.76
Primary tuberculosis 1 year after conversion from azathioprine to mycophenolate in recipient kidney transplantation: a case report. Transplant Proc (2003) 0.76
[Epidemiology of diabetes in Tunisia]. Tunis Med (1998) 0.76
HLA-unrestricted killing of HIV-1 gag protein-expressing CD4 T cells by gag-specific CD8 cytotoxic T cells. AIDS (1999) 0.75
[Ochratoxin A genotoxicity, relation to renal tumors]. Arch Inst Pasteur Tunis (1995) 0.75
[Duodenal tuberculosis associated with lymph node tuberculosis (apropos of a surgical case)]. Med Trop (Mars) (1985) 0.75
[Role of the determination of serum fructosamine in the screening of glucose intolerance]. Ann Biol Clin (Paris) (1994) 0.75
Cell-mediated immunity against HGP-30, a group-specific peptide of HIV p17 in individuals infected with the AIDS virus. Biomed Pharmacother (1992) 0.75
Altered MHC class I presented peptide repertoire is not sufficient to induce NK cell mediated F1-hybrid resistance. Mol Immunol (1995) 0.75
[Sampling protocol in an epidemiological population survey]. Tunis Med (1994) 0.75
[Pure venous gangrene. Apropos of a case]. Chirurgie (1986) 0.75
[Does vitamin E protect against experimental lithiasis?]. Ann Urol (Paris) (1994) 0.75
[The surgical field hospital in times of war or disasters]. Maroc Med (1985) 0.75
[Sudden onset polyradiculoneuritis in a patient with chronic renal failure]. Presse Med (1986) 0.75
Striking similarities between HIV-1 Env protein and the apoptosis mediating cell surface antigen Fas. Role in the pathogenesis of AIDS. Biomed Pharmacother (1993) 0.75
[The hollow foot, apropos of 4 cases]. Maroc Med (1985) 0.75
Polymerase chain reaction amplified HTLV-I, HIV-1 and HIV-2 DNA fragments in subjects with mixed retroviral infections. J Med Microbiol (1993) 0.75
[Antilithogenic and litholytic action of vitamin A vis-a-vis experimental calculi in rats]. Ann Urol (Paris) (1994) 0.75
Creatinine clearance in chronic renal failure. Comparison of direct measurement and calculation from serum creatinine. Nephron (1987) 0.75
[Preliminary note on anti-insulin antibody formation in diabetics treated with porcine insulin]. Arch Inst Pasteur Tunis (1984) 0.75
[Effect of variations of temperature on intestinal respiration and absorption of glycine in Discoglossus (Discoglossus pictus (Ott, 1837)]. Arch Inst Pasteur Tunis (1982) 0.75
[Injury-causing agents and anatomical lesions]. Maroc Med (1985) 0.75
[Effects of adrenaline and acetylcholine on respiratory exchanges of the cuttlefish, Sepia officinalis L., 1958, in a non-confined environment]. Arch Inst Pasteur Tunis (1978) 0.75
[Nephrotoxicity of iodine contrast media]. Ann Med Interne (Paris) (1987) 0.75